Position in GH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$385,460
+$78,019 QoQ
Shares Held
4,173
+38.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Alamea Verwaltungs GmbH holds $16,511,160 across 10 Diagnostics & Research names. GH ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
185,989 | $11,944,213 | |
| 2 | LH |
Labcorp Holdings Inc.
|
3,063 | $817,239 | |
| 3 | DGX |
Quest Diagnostics Inc
|
4,108 | $805,085 | |
| 4 | RVTY |
Revvity, Inc.
|
6,350 | $556,323 | |
| 5 | NTRA |
Natera, Inc.
|
2,761 | $552,172 | |
| 6 | QGEN |
Qiagen N.V.
|
13,288 | $532,051 | |
| 7 | GH |
Guardant Health, Inc.
This page
|
4,173 | $385,460 | |
| 8 | VCYT |
Veracyte, Inc.
|
11,055 | $356,081 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $385,460 | 4,173 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $307,441 | 3,010 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $312,025 | 4,994 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||